News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Endocyte, Inc. (ECYT) Closes Public Offering Of Common Stock


4/3/2014 8:50:21 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WEST LAFAYETTE, Ind., April 2, 2014 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT) announced today the closing of its previously announced underwritten public offering of 5,175,000 shares of its common stock at a price to the public of $21.00 per share, which includes the exercise in full by the underwriters of their option to purchase 675,000 additional shares. Endocyte received net proceeds of approximately $101.8 million from the offering after deducting underwriting discounts and commissions and estimated expenses relating to the offering.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES